Search form
Search
Login
Subscribe
Home
Country Intelligence
Industry Directory
Offsets / IC
Tenders
Australia
(21/week)
Haiti
(0/week)
Guyana
(0/week)
Honduras
(0/week)
Guatemala
(0/week)
View all
(21/week)
News
United States
(578/week)
Manufacturing
(398/week)
Energy
(304/week)
Technology
(413/week)
Environment
(238/week)
Events
About us
Who we are
Our People
Partners
Contact us
LinkedIn
Login
Twitter
Register
Home
News
NeuroVive Pharmaceutical AB
Feb 19, 2020
NeuroVive Pharmaceutical AB Year End Report January - December 2019
Dec 20, 2019
NeuroVive Completes Recruitment in the Second Part of its Ongoing KL1333 Clinical Phase Ia/b Study
Dec 16, 2019
NeuroVive Announces Settlement in Dispute With CicloMulsion AG
Nov 20, 2019
NeuroVive Pharmaceutical AB Interim Report January - September 2019
Aug 21, 2019
NeuroVive Pharmaceutical AB Interim Report January - June 2019
Aug 20, 2019
Save the Date: NeuroVive to host Capital Markets Day in Stockholm on 9 October, 2019
Mar 25, 2019
NeuroVive Pharmaceutical AB Publishes 2018 Annual Report
Mar 19, 2019
NeuroVive Enrolls First Subject in its KL1333 Phase Ia/b Clinical Study
Nov 15, 2018
NeuroVive Receives Vinnova Funding to Support Development of NV354, a Novel Treatment for Genetic Mitochondrial Disorders
Oct 10, 2018
NeuroVive Receives KL1333 Clinical Trial Regulatory Approval
Oct 04, 2018
NeuroVive Reports First NeuroSTAT Clinical Efficacy Signal in TBI
Sep 06, 2018
NeuroVive Receives Positive FDA Feedback on its NeuroSTAT TBI Development Plan
Aug 28, 2018
NeuroVive's NVP015 Program Will be Accelerated Through Award of Major Research Grant to Children's Hospital of Philadelphia
Aug 21, 2018
NeuroVive Pharmaceutical AB Interim Report January - June 2018
Jun 18, 2018
NeuroVive out-licenses targeted LHON therapy to BridgeBio Pharma's new subsidiary Fortify Therapeutics
May 31, 2018
Amended Number of Shares and Votes in NeuroVive Pharmaceutical AB (publ)
May 22, 2018
NeuroVive Pharmaceutical AB Interim Report January - March 2018
May 21, 2018
NeuroVive and Yungjin Reports Positive KL1333 Phase I Clinical Study Results Paving the way for Further Clinical Development
May 02, 2018
NeuroVive Initiates Collaboration With Leading US TBI Research Organization
Apr 27, 2018
Amendment: Resolutions From Annual General Meeting in NeuroVive Pharmaceutical AB (publ)
Page 1
››
Latest News
Apr 26, 2024
OpenGate Capital Completes Sale of SMAC
Apr 26, 2024
Masonite Shareholders Approve Transaction with Owens Corning
Apr 26, 2024
Avery Dennison Increases Quarterly Dividend
Apr 26, 2024
ComEd Joins Bronzeville Community to Unveil New Public EV Chargers
Apr 26, 2024
OCOchem Advances Hydrogen Formate Electrolyzer Process By 10x To Create World’s Largest Industrial Scale CO2...
Apr 26, 2024
Canada Tractors Industry Analysis & Forecasts 2023-2024 and 2029: Technological Advancements and Shift...
Apr 26, 2024
Global and Regional Aircraft Fuel Cells Industry Research 2023-2033: Integration into Aircraft Systems Drives...
Apr 26, 2024
Leeward Renewable Energy Releases Inaugural Sustainability Highlights Report
View all News
Agenda
24
September
Hilton London Syon Park, London, UK
Defence Transformation Conference
Returning for its 8th year, Defence Transformation 2024 will feature an updated format that will address all aspects of...
17
June
France
Parc des Expositions de Paris Nord Villepinte ZAC Paris Nord 2, 93420 Villepinte – France (Halls 5a – 5b – 6)
Eurosatory 2024, 17 - 21 June 2024, Parc des Expositions de Paris Nord Villepinte ZAC Paris Nord 2, 93420 Villepinte – France (Halls 5a – 5b – 6)
Eurosatory 2024 There can be no sustainable world without peace and security. Founded in 1967, the exhibition...
21
May
Paris Marriott Rive Gauche & Conference Center
Future Artillery, 21-23 May 2024, Paris Marriott Rive Gauche & Conference Center, France
DELIVERING FIRES IN THE MULTI-DOMAIN BATTLESPACE As artillery reasserts itself as the ‘King of Battlefield’ in the wake...
View All Events